Preclinical Research

New York, September 2, 2026 SELLAS Life Sciences Group, Inc. announced that three abstracts evaluating SLS009 (tambiciclib), a potent...

Westlake Village, California, August 20, 2026 Turn Therapeutics announced new peer-reviewed research providing in-vivo evidence that GX-03 selectively reduces...

THE WOODLANDS, Texas, August 12, 2026 Autonomix Medical, Inc. announced the successful completion of a Good Laboratory Practice (GLP)...

SAN RAFAEL, Calif. & SAN DIEGO, July 27, 2026 BioMarin Pharmaceutical Inc. and the n-Lorem Foundation have announced a...

WATERTOWN, Mass., July 27, 2026 Neumora Therapeutics announced positive preclinical toxicology results for NMRA-215, its investigational brain-penetrant oral NLRP3...

MILWAUKEE, July 21, 2026 Estrigenix Therapeutics announced the first closing of its $2 million Series Seed financing, led by...

Tampa, Florida, USA & London, UK | July 21, 2026 Akari Therapeutics announced a strategic research collaboration with Whitehawk...

BERKELEY HEIGHTS, N.J., July 15, 2026 Tonix Pharmaceuticals announced the publication of new preclinical research in the Journal of...

SAN DIEGO, July 15, 2026 Sinopia Biosciences announced the publication of preclinical research in Science Translational Medicine supporting SB-0110,...

SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...